Kensington Investment Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enerpac Tool Group
EPAC
|
+$2.06M |
| 2 |
LKQ Corp
LKQ
|
+$1.2M |
| 3 |
Duolingo
DUOL
|
+$1.15M |
| 4 |
EXL Service
EXLS
|
+$1.14M |
| 5 |
Qualcomm
QCOM
|
+$325K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.31M |
| 2 |
Edwards Lifesciences
EW
|
+$1.21M |
| 3 |
Nasdaq
NDAQ
|
+$1.1M |
| 4 |
ResMed
RMD
|
+$568K |
| 5 |
Monster Beverage
MNST
|
+$413K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.3% |
| 2 | Industrials | 19.47% |
| 3 | Healthcare | 14.19% |
| 4 | Consumer Discretionary | 12.28% |
| 5 | Financials | 8.37% |
Similar funds
Kensington Investment Counsel's Q2 2024 Portfolio in Review
As of Q2 2024, Kensington Investment Counsel held 111 positions worth $226M, up 3.2% from $219M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Kensington Investment Counsel deployed $6.9M of net new capital in Q2 2024, opening 14 new positions and adding to 58 existing holdings. Its largest new stake was Enerpac Tool Group: 55,689 shares worth $2.13M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Nasdaq, an estimated $1.1M trimmed.
- Kensington Investment Counsel's largest Q2 2024 buy was Enerpac Tool Group: 55,689 shares worth $2.13M.
- Kensington Investment Counsel added most to LKQ Corp in Q2 2024, an estimated $1.2M increase.
- Kensington Investment Counsel's biggest Q2 2024 reduction was Nasdaq, cutting an estimated $1.1M.
- Kensington Investment Counsel fully exited Bristol-Myers Squibb in Q2 2024, selling an estimated $1.31M.
- Kensington Investment Counsel's ten largest holdings make up 33% of its $226M portfolio in Q2 2024.
- Kensington Investment Counsel opened 14 new positions and closed 3 in Q2 2024.
- Kensington Investment Counsel's portfolio value rose 3.2% quarter-over-quarter to $226M.
Based on Kensington Investment Counsel's 13F filing for Q2 2024, filed 14 Aug 2024.